Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 3 1Phase 2 1Phase 1/2 1

Status

Recruiting 3Withdrawn 1Completed 1

Sponsor Class

OTHER 10INDUSTRY 5NIH 4NETWORK 1

Study Type

Interventional 5

Sponsor

Conditions

Neoplasms 1522Carcinoma, Non-Small-Cell Lung 757Breast Neoplasms 572Neoplasm Metastasis 531Colorectal Neoplasms 447Melanoma 391Leukemia, Myeloid, Acute 372Multiple Myeloma 364Ovarian Neoplasms 354Recurrence 336Lymphoma 334Advanced Solid Tumors 325Lymphoma, Non-Hodgkin 315Prostatic Neoplasms 300Pancreatic Neoplasms 285Advanced Solid Tumor 240Stomach Neoplasms 233Carcinoma, Renal Cell 226Squamous Cell Carcinoma of Head and Neck 211Lung Neoplasms 210Solid Tumor 204Leukemia, Lymphocytic, Chronic, B-Cell 198Triple Negative Breast Neoplasms 184Solid Tumors 183Carcinoma, Hepatocellular 165Hematologic Neoplasms 155Head and Neck Neoplasms 153Lymphoma, Large B-Cell, Diffuse 148Lymphoma, Follicular 146Glioblastoma 145

Interventions

spartalizumab 1Interleukin-2 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × Drug-Related Side Effects and Adverse Reactions × Clear all
NCT07238075 2026-02-17

ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers

Adcytherix SAS

Phase 1 Recruiting
290 enrolled

Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT05417750 2025-12-10

MIZAR-001

Shanghai Juncell Therapeutics

Phase 1 Completed
43 enrolled

Drug-Related Side Effects and Adverse Reactions

NCT06716619 2025-03-26

A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors

Guangzhou FineImmune Biotechnology Co., LTD.

Phase 1 Recruiting
32 enrolled

Drug-Related Side Effects and Adverse Reactions

NCT06302062 2024-12-03

TAL-T

Guangzhou FineImmune Biotechnology Co., LTD.

Phase 1 Recruiting
23 enrolled

Drug-Related Side Effects and Adverse Reactions

NCT03077477 2018-06-14

Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers

Aminex Therapeutics, Inc.

Phase 1 Withdrawn

Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡